Stereotaxis’s suite of proprietary magnetic coronary guidewires including CRONUS, ASSERT and TITAN, suitable for use in ...
ProSolv CardioVascular, a FUJIFILM company, recently released ProSolv CardioVascular 4.0, a new software release ...
August 27, 2008 - Cordis Corp. today said it received CE mark approval to market the CYPHER SELECT Plus Sirolimus ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
August 27, 2008 - XDx Inc. said today it received market clearance from the FDA for AlloMap Molecular Expression Testing ...
Terumo Interventional Systems will feature its Runthrough NS coronary guidewire at TCT 2008. The Runthrough NS ...
August 27, 2008 - Stereotaxis Inc. announced yesterday the FDA clearance of its magnetically tipped PowerAssert ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
August 27, 2008 - The Children's Hospital at Montefiore (CHAM) in the Bronx recently received approval as a pediatric heart transplant center by the New York State Department of Health. On the strength of a newly recruited pediatric cardiology team, specialists at CHAM can now treat any congenital or acquired heart abnormality in children and adolescents.
Stentys, a French-based company, will feature its bifurcated stent at TCT 2008. The patent-pending bifurcated stent is ...
Aug. 27, 2008 — Electrocardiographically gated 64-multidetector row coronary computed tomographic angiography (CCTA) was ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the ...
August 26, 2008 - In a major landmark for advanced interventional technology to treat aortic disease, the Zenith Branch ...
Atrium Medical Corp.’s ClearWay RX is a therapeutic perfusion catheter indicated for localized delivery of therapeutic agents to the coronary and peripheral vasculature.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
August 26, 2008 - Anthera Pharmaceuticals Inc. yesterday announced the initiation of the FRANCIS (Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression) clinical trial to examine the impact of varespladib when administered to patients within 96 hours of an acute coronary syndrome (ACS) event.
August 26, 2008 - Corgenix Medical Corp. announced its collaboration with BG Medicine whereby Corgenix' AtherOx products ...
The Twin-Pass and Twin-Pass .023-inch dual access catheters feature an over-the-wire lumen and a rapid exchange lumen in ...
August 27, 2008
